Compare Shanghai INT Medical Instruments Co., Ltd. with Similar Stocks
Dashboard
1
Company has very low debt and has enough cash to service the debt requirements
- OPERATING CASH FLOW(Y) Highest at HKD 636.12 MM
- RAW MATERIAL COST(Y) Fallen by -5.36% (YoY)
- CASH AND EQV(HY) Highest at HKD 725.73 MM
2
With ROE of 10.55%, it has a Fair valuation with a 3.16 Price to Book Value
3
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.61%
0%
25.61%
6 Months
24.69%
0%
24.69%
1 Year
24.92%
0%
24.92%
2 Years
21.57%
0%
21.57%
3 Years
94.51%
0%
94.51%
4 Years
-18.95%
0%
-18.95%
5 Years
-45.36%
0%
-45.36%
Shanghai INT Medical Instruments Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.51%
EBIT Growth (5y)
13.10%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.39
Tax Ratio
10.92%
Dividend Payout Ratio
19.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.07%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
3.15
EV to EBIT
31.12
EV to EBITDA
21.90
EV to Capital Employed
3.09
EV to Sales
6.59
PEG Ratio
1.48
Dividend Yield
NA
ROCE (Latest)
9.93%
ROE (Latest)
10.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,155.50
923.70
25.09%
Operating Profit (PBDIT) excl Other Income
352.60
291.40
21.00%
Interest
13.60
2.60
423.08%
Exceptional Items
7.50
-9.40
179.79%
Consolidate Net Profit
238.70
206.10
15.82%
Operating Profit Margin (Excl OI)
207.30%
221.80%
-1.45%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 25.09% vs 11.03% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 15.82% vs 21.74% in Dec 2024
About Shanghai INT Medical Instruments Co., Ltd. 
Shanghai INT Medical Instruments Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






